ACE inhibitors had a higher risk for all-cause mortality, CV mortality, angioedema, transient ischemic attack, dementia, renal disorders, thrombocytopenia, gastrointestinal
[medscape.com]
congestive heart failure.
[ncbi.nlm.nih.gov]
Therefore, in a cohort of ACEI-treated patients with congestive heart failure (CHF), we investigated the predictive value of two pharmacogenetic scores that previously were
[ncbi.nlm.nih.gov]